1 / 20

Immune System Disorders

Immune System Disorders. What is an allergy anyway?. Hypersensitivity Reactions. Response to antigens (allergens) leading to damage Require sensitizing dose(s). Type I (Anaphylactic) Reactions. Involve IgE antibodies Localized: Hives or asthma from contact or inhaled antigens

virgo
Download Presentation

Immune System Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immune System Disorders What is an allergy anyway?

  2. Hypersensitivity Reactions • Response to antigens (allergens) leading to damage • Require sensitizing dose(s)

  3. Type I (Anaphylactic) Reactions • Involve IgE antibodies • Localized: Hives or asthma from contact or inhaled antigens • Systemic: Shock from ingested or injected antigens Figure 19.1a

  4. Type I (Anaphylactic) Reactions • Skin testing • Desensitization Figure 19.3

  5. Type II (Cytotoxic) Reactions • Involve IgG or IgM antibodies and complement • Complement activation causes cell lysis or damage by macrophages

  6. Hemolytic Disease of the Newborn Figure 19.4

  7. Drug-induced Thrombocytopenic Purpura Figure 19.5

  8. Type III (Immune Complex) Reactions • IgG antibodies and antigens form complexes that lodge in basement membranes. Figure 19.6

  9. Type IV (Cell-Mediated) Reactions • Delayed-type hypersensitivities due to TD cells • Cytokines attract macrophages and initiate tissue damage Figure 19.8

  10. Autoimmune Diseases • Clonal deletion during fetal development ensures self-tolerance • Autoimmunity is loss of self-tolerance

  11. Autoimmune Diseases • Type I — Due to antibodies against pathogens • Type II — Antibodies react with cell-surface antigens • Type III (Immune Complex) — IgM, IgG, complement immune complexes deposit in tissues • Type IV — Mediated by T cells

  12. Reactions Related to the Human Leukocyte Antigen (HLA) Complex • Histocompatibility antigens: Self antigens on cell surfaces • Major histocompatibility complex (MHC): Genes encoding histocompatibility antigens • Human leukocyte antigen (HLA) complex: MHC genes in humans

  13. Diseases Related to Specific HLAs Table 19.3

  14. HLA Typing Figure 19.1

  15. Reactions to Transplantation • Transplants may be attacked by T cells, macrophages, and complement-fixing antibodies. • Transplants to privileged sites do not cause an immune response. • Stem cells may allow therapeutic cloning to avoid rejection.

  16. Grafts • Autograft: Use of one's own tissue • Isograft: Use of identical twin's tissue • Allograft: Use of tissue from another person • Xenotransplantation product: Use of non-human tissue • Graft-versus-host disease can result from transplanted bone marrow that contains immunocompetent cells

  17. Immunosuppression prevents an immune response to transplanted tissues • Cyclosporine suppresses IL-2 • Mycophenolate mofetil inhibits T cell and B cell reproduction • Sirolimus blocks IL-2

  18. Immune Deficiencies • Congenital: Due to defective or missing genes • Selective IgA immunodeficiency • Severe combined immunodeficiency • Acquired: Develop during an individual's life, due to drugs, cancers, infections • Artificial: Immunosuppression drugs • Natural: HIV infections

  19. The Immune System and Cancer • Cancer cells possess tumor-specific antigens • TC cells recognize and lyse cancer cells • Cancer cells may lack tumor antigens or kill TC cells Figure 19.11

  20. Immunotherapy • Treatment of cancer using immunologic methods • Tumor necrosis factor, IL-2, and interferons may kill cancer cells • Immunotoxins link poisons with an monoclonal antibody directed at a tumor antigen • Vaccines contain tumor-specific antigens

More Related